在初级保健中实施改进的哮喘自我管理常规(IMP2ART):集群随机对照实施试验的研究方案
IMP2ART是一项平行组集群随机对照混合II型实施试验,计划纳入144家全科诊所,比较 facilitated 实施策略与常规照护。主要临床结局为随机化后第二年间(12至24个月)计划外诊疗的组间差异,主要实施结局为12个月时哮喘行动计划拥有率。
要点
- 试验纳入144家全科诊所,随机分配至IMP2ART实施策略组或对照组。
- 主要临床结局为随机化后12至24个月计划外诊疗的组间差异,基于常规数据评估。
- 主要实施结局为12个月时哮喘行动计划拥有率,通过问卷评估随机抽取的哮喘患者亚组。
核心结论
- 该实施试验旨在确定 facilitated 实施IMP2ART策略是否能增加哮喘行动计划的提供并减少计划外诊疗。
研究设计与样本
- IMP2ART为平行组、集群随机对照混合II型实施试验,144家全科诊所将随机分配至IMP2ART实施策略组或对照组。
主要发现
- 实施组诊所将在 facilitation 工作坊后获得组织资源以帮助其优先开展支持性自我管理(包括审计与反馈;IMP2ART哮喘审查模板),以及专业人员培训和支持患者自我管理的资源。
- 对照组继续接受常规哮喘照护。
- 主要临床结局为随机化后第二年间(即随机化后12至24个月)计划外诊疗的组间差异,基于常规数据评估。
- 主要实施结局为12个月时哮喘行动计划拥有率,通过问卷对随机抽取的哮喘患者亚组进行评估。
- 次要结局包括哮喘审查次数、处方结局(缓解药物和口服激素)、哮喘症状控制、患者自我管理信心及专业支持与资源使用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Asthma is a common long-term condition and major public health problem. Supported self-management for asthma that includes a written personalised asthma action plan, supported by regular professional review, reduces unscheduled consultations and improves asthma outcomes and quality of life. However, despite unequivocal inter/national guideline recommendations, supported self-management is poorly implemented in practice. The IMPlementing IMProved Asthma self-management as RouTine (IMP2ART) implementation strategy has been developed to address this challenge. The aim of this implementation trial is to determine whether facilitated delivery of the IMP2ART strategy increases the provision of asthma action plans and reduces unscheduled care in the context of routine UK primary care. METHODS: IMP2ART is a parallel group, cluster randomised controlled hybrid II implementation trial. One hundred forty-four general practices will be randomly assigned to either the IMP2ART implementation strategy or control group. Following a facilitation workshop, implementation group practices will receive organisational resources to help them prioritise supported self-management (including audit and feedback; an IMP2ART asthma review template), training for professionals and resources to support patients to self-manage their asthma. The control group will continue with usual asthma care. The primary clinical outcome is the between-group difference in unscheduled care in the second year after randomisation (i.e. between 12 and 24 months post-randomisation) assessed from routine data. Additionally, a primary implementation outcome of asthma action plan ownership at 12 months will be assessed by questionnaire to a random sub-group of people with asthma. Secondary outcomes include the number of asthma reviews conducted, prescribing outcomes (reliever medication and oral steroids), asthma symptom control, patients' confidence in self-management and professional support and resource use. A health economic analysis will assess cost-effectiveness, and a mixed methods process evaluation will explore implementation, fidelity and adaptation. DISCUSSION: The evidence for supported asthma self-management is overwhelming. This study will add to the literature regarding strategies that can effectively implement supported self-management in primary care to reduce unscheduled consultations and improve asthma outcomes and quality of life. TRIAL REGISTRATION: ISRCTN15448074. Registered on 2 December 2019.
引用
- McClatchey K, Hammersley V, Steed L, et al. IMPlementing IMProved Asthma self-management as RouTine (IMP2ART) in primary care: study protocol for a cluster randomised controlled implementation trial. Trials. 2023. PMID: 37013577. doi:10.1186/s13063-023-07253-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。